NCT00362947View on ClinicalTrials.gov

Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis

PHASE3CompletedINTERVENTIONAL

Enrollment

664

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2010

Study Completion Date

February 28, 2011

Conditions

Thrombophlebitis

Interventions

DRUG

LMWH parnaparin subcutaneously

Trial Locations (2)

29100

U.O. Medicina Critica, Piacenza

40138

Dept. Angiology & Blood Coagulation; University Hospital S.Orsola-Malpighi, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT00362947 - Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis | Biotech Hunter | Biotech Hunter